Vimarsana
Biggest News Aggregation in the World

Page 13 - Compass Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compass Pathways Today - Breaking & Trending Today

COMPASS Pathways (CMPS) Set to Announce Earnings on Monday - Vimarsana News

COMPASS Pathways (CMPS) Set to Announce Earnings on Monday

COMPASS Pathways (NASDAQ:CMPS – Get Free Report) is set to post its quarterly earnings results on Monday, February 5th. COMPASS Pathways (NASDAQ:CMPS – Get Free Report) last issued its quarterly earnings data on Thursday, November 2nd. The company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.17). […]

Source: wkrb13.com
As investors pile into psychedelics, idealism gives way to pharma economics - Vimarsana News

As investors pile into psychedelics, idealism gives way to pharma economics

Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental

As investors pile into psychedelics, idealism gives way to pharma economics – Winnipeg Free Press - Vimarsana News

As investors pile into psychedelics, idealism gives way to pharma economics – Winnipeg Free Press

Breaking News, Sports, Manitoba, Canada

As investors pile into psychedelics, idealism gives way to pharma economics - Vimarsana News

As investors pile into psychedelics, idealism gives way to pharma economics

Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for…

Source: wtop.com
As investors pile into psychedelics, idealism gives way to pharma economics – Metro US - Vimarsana News

As investors pile into psychedelics, idealism gives way to pharma economics – Metro US

Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental health conditions. While psychedelics are still illegal under federal law, companies are jostling to try and patent key ingredients found in magic mushrooms, ayahuasca and […]

Source: metro.us